MicroVention is a rapidly growing medical device company that has pioneered the development of catheter-based, minimally invasive, neuroendovascular technologies that provide therapeutic advantages for neurovascular disorders. We are a worldwide community of over 2000 engineers, chemists, marketers, manufacturers, researchers, and innovators who share the same ethos — creating technologies that provide a meaningful improvement in patient lives. From the beginning, we sought to develop and market medical devices that would improve the treatment of diseases in small blood vessels. After developing some early concepts and prototypes, our company narrowed its focus to aneurysm therapy, developing a line of implantable, detachable neuroendovascular platinum coils. In 2006, we were acquired by the Japan-based Terumo® Corporation. Terumo provided the framework for MicroVention to operate autonomously and grow freely. Today, we have launched over 30 products and have expanded beyond cerebral aneurysms, to include treatment for ischemic stroke, carotid artery disease, and neurovascular malformations.